Analyst stock forecast
Trevi Therapeutics Stock Forecast and Analyst Price Target
TRVI analyst target range, upside, consensus rating and coverage count.
Direct answer
Trevi Therapeutics's average price target is $26.18.
The target implies +40.4% from the recorded current price, and the consensus rating is none.
The verified range is $20.00 to $36.00, with 11 analysts in the current consensus when available.
Forecast evidence checked August 6, 2026.
Verified data
- Current price
- $18.65
- Average price target
- $26.18
- High price target
- $36.00
- Low price target
- $20.00
- Target upside
- +40.4%
- Consensus rating
- none
- Analysts
- 11
- Evidence date
- August 6, 2026
- Valid through
- August 13, 2026